Call us at (888) 828-2206. We'll help answer any questions you may have.
SAR442085 is a monoclonal antibody that targets the CD38 protein on certain cells.
On February 4, 2022, it was announced that Sanofi will no longer continue development on SAR442085 in multiple myeloma.
February 04, 2022
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.
Create My Account